NCT01526798View on ClinicalTrials.gov

Improvement of EPO-resistance in Hemodialysis Patients With Chronic Inflammation by High Cut-off Hemodialysis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

End-Stage Renal Disease (ESRD)

Interventions

DEVICE

Theralite (high cut-off hemodialysis)

Hemodialysis with Theralite dialyzer alternating with standard high-flux dialyzer

DEVICE

Conventional high-flux dialyzer

Trial Locations (1)

20021

Azienda Ospedaliera Garbagnate Milanese Ospedale Bollate - Divisione Nefrologia e Dialisi, Bollate

All Listed Sponsors

collaborator

Gambro Dialysatoren GmbH

INDUSTRY

collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Vantive Health LLC

INDUSTRY

NCT01526798 - Improvement of EPO-resistance in Hemodialysis Patients With Chronic Inflammation by High Cut-off Hemodialysis | Biotech Hunter | Biotech Hunter